WithdrawnPhase 2NCT00438243
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Alisa Kim, MDJohns Hopkins University
- Intervention
- Bromfenac (Xibrom)(drug)
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2010
Study locations (1)
- The Johns Hopkins Hospital, Baltimore, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00438243 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.